Ibogamin-20-ol,12,13-dimethoxy-, (20S)- (9CI)(61431-40-1)
- Name: Ibogamin-20-ol,12,13-dimethoxy-, (20S)- (9CI)
- Synonyms:6,9-Methano-5H-pyrido[1',2':1,2]azepino[4,5-b]indole,ibogamin-20-ol deriv.; 20S-Hydroxyibogaline; Iboxygaline
- Molecular Formula:C21H28 N2 O3
- Molecular Weight:
- CAS Registry Number:61431-40-1
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 126193-55-3/5-chloro-N-(4-methyl-1,3-thiazol-2-yl)-2-phenyl-1H-indol-3-amine
- 68958-76-9/2-Propenoic acid, 2-methyl-, methyl ester, polymer with butyl 2-propenoate, 1,2-propanediol mono(2-methyl-2-propenoate) and 2-propenoic acid, compd. with 2-(dimethylamino)ethanol
- 13302-67-5/naphthalene-1,2,4-triol
- 63698-78-2/3-{[5-(1,3-benzodioxol-5-yl)-1,3,4-oxadiazol-2-yl]sulfanyl}-N,N-dimethylpropan-1-amine
- 55281-94-2/1,2,3,4,4a,7,8,9,10,11,12,12a-Dodecahydro-6-octylchrysene
- 93921-06-3/Cuprate(6-),[2-[[[[3-[[4-chloro-6-[[4-[[4-chloro-6-[(3-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2,5-disulfophenyl]amino]-1,3,5-triazin-2-yl]amino]-2-hydroxy-5-sulfophenyl]azo]phenylmethyl]azo]-5-sulfobenzoato(8-)]-,hexahydrogen, (SP-4-3)- (9CI)
- 12765-33-2/Hexin
- 13297-36-4/3-propylquinoxalin-2(1H)-one
- 156171-04-9/(1R,9aR)-1-{[(1H-indol-3-ylmethyl)sulfanyl]methyl}octahydro-2H-quinolizine
- 84916-57-4/Decanoic acid, 1-((octahydro-1,3-dioxo-2H-isoindol-2-yl)methyl)-2-(4-( 2-pyridinyl)-1-piperazinyl)ethyl ester, (Z)-2-butenedioate (1:2)
- 123226-48-2/9-bromo-11-({2-[(phenylsulfonyl)amino]ethyl}sulfanyl)-6,11-dihydrodibenzo[b,e]oxepine-2-carboxylic acid
- 105418-68-6/6-Isoquinolinol,1,2,3,4-tetrahydro-7-methoxy-2-methyl-1-[[4-[[(6aS)-5,6,6a,7-tetrahydro-1,2,3,9,10-pentamethoxy-6-methyl-4H-dibenzo[de,g]quinolin-8-yl]oxy]phenyl]methyl]-,(1S)-
- 57308-12-0/Magnesium,bis[N-(N-acetyl-L-a-aspartyl)-L-glutamato(2-)]tri- (9CI)
- 5302-80-7/2-{[5-(4-chlorophenyl)-4-(furan-2-ylmethyl)-4H-1,2,4-triazol-3-yl]sulfanyl}-N-(3,4-difluorophenyl)acetamide
- 40436-51-9/Uridine-5-d (9CI)
- 61766-90-3/N,N-diethyl-5-hydrazinyl-4-methyl-1,2-benzothiazepin-3-amine 1,1-dioxide
- 91771-48-1/Cinnamomum culilawan,ext.
- 184288-37-7/2(5H)-Furanone,3-[(13R)-13-hydroxy-13-[(2R,2'R,5R,5'R)-octahydro-5'-[(1S,8R,9S)-1,8,9-trihydroxyundecyl][2,2'-bifuran]-5-yl]tridecyl]-5-methyl-,(5S)-
- 5322-14-5/1-(2-methylphenyl)-5-phenyl-1H-tetrazole
- 61431-40-1/Ibogamin-20-ol,12,13-dimethoxy-, (20S)- (9CI)
- 21416-57-9/6-[(2,3-dimethylphenyl)amino]pyrimidine-2,4(1H,3H)-dione
- 16929-54-7/2-(2-chloroethyl)-1,3-dimethoxybenzene
- 70591-77-4/(4aR,11aS)-1,2,3,4,4a,6,7,8,9,11a-decahydro-11H-pyrido[2,1-b]quinazolin-11-one
- 99811-84-4/1,4-Benzenedicarboxylic acid, polymers with bisphenol A, caprolactam-blocked 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane-trimethylolpropane polymer, epichlorohydrin, 4,4-methylenebis(benzenamine), triethylene glycol, trimellitic anhydride and 1,3,5-tris(2-hydroxyethyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione
- 129836-16-4/Benzenediazonium,4-(6-methyl-7-sulfo-2-benzothiazolyl)-2-sulfo-, inner salt
- 70983-90-3/Fatty acids, vegetable-oil, polymers with bisphenol A, epichlorohydrin and tetraethylenepentamine
- 16757-83-8/4-Methylbenzo[a]pyrene
- 138994-73-7/b-D-Glucopyranoside,4-[(4S,5R)-5-(3,4-dihydroxyphenyl)-5-hydroxy-4-[[2-O-[(2E)-3-(4-hydroxyphenyl)-1-oxo-2-propenyl]-b-D-glucopyranosyl]oxy]-1-pentynyl]-2-hydroxyphenyl(9CI)
- 93637-64-0/1H-Imidazole-1-aceticacid, 4-(4-propoxyphenyl)-,2-[[4-[bis(2-chloroethyl)amino]phenyl]methylene]hydrazide
- 13030-86-9/5,7-dimethyl-3,4,5,6,7,8-hexahydro-2H-chromene